The released interleukin 2 receptor binds interleukin 2 efficiently
- PMID: 3023487
The released interleukin 2 receptor binds interleukin 2 efficiently
Abstract
The released interleukin 2 receptor (IL 2R) molecule was characterized in order to clarify its biochemical structure and to determine its functional capacity. Enzymatic digestions demonstrated that the released IL 2R, like the cell surface IL 2R, is a complex glycoprotein, modified by the addition of both N- and O-linked carbohydrates and sialic acid residues. It has a peptide backbone that is approximately 10 Kd smaller than that of its membrane-associated counterpart. Affinity chromatography demonstrated that released IL 2R from either an HTLV-I-positive T cell line (HUT-102) or PHA-activated normal peripheral lymphocytes binds efficiently to purified recombinant IL 2. Furthermore, the interaction between the growth factor and the released receptor does not appear to require any accessory molecules. These observations suggest a potentially significant role for the released IL 2R in the regulation of IL 2-dependent lymphocyte functions.
Similar articles
-
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.J Immunol. 1985 Nov;135(5):3172-7. J Immunol. 1985. PMID: 3930598
-
High levels of soluble interleukin 2 receptors released from human retrovirus-infected cells.Jpn J Cancer Res. 1987 Sep;78(9):889-93. Jpn J Cancer Res. 1987. PMID: 2889714
-
Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines.J Immunol. 1987 Dec 1;139(11):3680-4. J Immunol. 1987. PMID: 3119713
-
An overview of the human interleukin-2 receptor: molecular, biochemical, and functional properties.Cancer Invest. 1987;5(4):369-76. Cancer Invest. 1987. PMID: 2889515 Review. No abstract available.
-
Analysing lymphokine-receptor interactions of IL-1 and IL-2 by recombinant-DNA technology.Trends Biotechnol. 1991 Jul;9(7):250-7. doi: 10.1016/0167-7799(91)90079-w. Trends Biotechnol. 1991. PMID: 1368709 Review.
Cited by
-
Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia.PLoS One. 2013;8(1):e55818. doi: 10.1371/journal.pone.0055818. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23383287 Free PMC article.
-
Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.Br J Cancer. 1998 Jun;77(11):1820-4. doi: 10.1038/bjc.1998.302. Br J Cancer. 1998. PMID: 9667652 Free PMC article.
-
Interleukin-2 and interferon in renal cell carcinoma.Med Oncol Tumor Pharmacother. 1993;10(1-2):71-6. doi: 10.1007/BF02987771. Med Oncol Tumor Pharmacother. 1993. PMID: 7505042 Review.
-
Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.Arch Dis Child. 1994 Jul;71(1):35-9. doi: 10.1136/adc.71.1.35. Arch Dis Child. 1994. PMID: 8067791 Free PMC article. Clinical Trial.
-
Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting.Mediators Inflamm. 2020 Sep 28;2020:6259064. doi: 10.1155/2020/6259064. eCollection 2020. Mediators Inflamm. 2020. PMID: 33061828 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources